paperKB
coga / coga-kb
Processing
Help
Sign in

Chunk #24 — MATERIALS AND METHODS — Medication Compliance Measurement

Source
Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
Embedded
yes

Text

Mean peak blood alcohol concentrations (BAC) done after the priming drink targeted at 20-30mg% (equivalent to 2 standard drinks) in fact ranged from 21-26mg% for the four OPRM1 gene by medication groups and was not statistically significant.